Clinical Trial

Combination CurQD and Vedolizumab in Ulcerative Colitis

Study acronym: Curve UC
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to test the efficacy and safety of the study intervention, CurQD or placebo (non-active pill), in combination with vedolizumab prescribed as standard of care for patients with ulcerative colitis (UC)..
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-18.
Trial Details
NCT Number NCT07665294
Lead Sponsor Ryan C Ungaro
Collaborators: United States Department of Defense
Conditions Ulcerative Colitis
Enrollment 160 participants
Start Date 2026-10-01
Primary Completion 2027-06-23 (estimated)
Study Completion 2027-06-23 (estimated)
Updated on ClinicalTrials.gov 2026-07-27